Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
Cell Research
|
May 9, 2015
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo, Michael J Morgan, Da-Gyum Lee, et al.
Cancer Discovery
|
June 26, 2023
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
Shanshan Pei, Ian T Shelton, Austin E Gillen, et al.
Haematologica
|
February 26, 2026
Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy
Justin Watts, Ellen Madarang, Diana Abbott, et al.
Cancer Discovery
|
May 24, 2024
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
Anagha Inguva Sheth, Mark J Althoff, Hunter Tolison, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2016
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Ruben Mesa, Catriona Jamieson, Ravi Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2023
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study
David A Sallman, Monzr M Al Malki, Adam S Asch, et al.
Ejhaem
|
July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease Registry
Daniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
Blood
|
October 20, 2022
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
Naval G Daver, Monique Dail, Jacqueline S Garcia, et al.
International Journal of Laboratory Hematology
|
November 21, 2020
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes
Jay L Patel, Mehrdad Abedi, Christopher R Cogle, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 20, 2024
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial
Marina Y Konopleva, Monique Dail, Naval G Daver, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
Cell Research
|
May 9, 2015
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo, Michael J Morgan, Da-Gyum Lee, et al.
Cancer Discovery
|
June 26, 2023
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
Shanshan Pei, Ian T Shelton, Austin E Gillen, et al.
Haematologica
|
February 26, 2026
Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy
Justin Watts, Ellen Madarang, Diana Abbott, et al.
Cancer Discovery
|
May 24, 2024
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
Anagha Inguva Sheth, Mark J Althoff, Hunter Tolison, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2016
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Ruben Mesa, Catriona Jamieson, Ravi Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2023
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study
David A Sallman, Monzr M Al Malki, Adam S Asch, et al.
Ejhaem
|
July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease Registry
Daniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
Blood
|
October 20, 2022
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
Naval G Daver, Monique Dail, Jacqueline S Garcia, et al.
International Journal of Laboratory Hematology
|
November 21, 2020
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes
Jay L Patel, Mehrdad Abedi, Christopher R Cogle, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 20, 2024
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial
Marina Y Konopleva, Monique Dail, Naval G Daver, et al.
Page
of 15